PO.TB03.02 · 肿瘤生物学

利用新型无异源且具生物功能的水凝胶系统开发由上皮-间质转化驱动的先进类肿瘤模型

Developing advanced tumoroid models driven by epithelial-to-mesenchymal transition with a novelxeno-free andbiofunctionalhydrogel system

编号 4832 展板 6 时间 4/21 09:00–12:00 区域 Section 27 主讲 Alejandra Ferrer Díaz, PhD
分会场 Epithelial-to-Mesenchymal Transition
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Alejandra I. Ferrer Díaz, John Huang

TheWell Bioscience, Inc, Monmouth Junction, NJ

摘要 Abstract

中文摘要
上皮-间质转化(EMT)是促进癌症向远处器官转移的关键生物学过程。大多数研究EMT的临床前研究采用传统的二维(2D)培养模型进行,这些模型无法重现体内肿瘤微环境,限制了其研究结果在临床环境中的转化相关性。因此,三维(3D)培养系统已成为模拟转移过程和评估候选治疗药物的优越方法。然而,这些模型通常依赖于动物源性细胞外基质如Matrigel,其成分定义不清、批次间存在差异、且缺乏力学和生化稳定性,从而损害了实验的可重复性和临床转化。在本研究中,我们使用VitroGel®水凝胶(一种全合成且生物相容的水凝胶系统)从两种已知会发生EMT的癌症类型——多形性胶质母细胞瘤(GBM)和乳腺癌——构建了类肿瘤。VitroGel®水凝胶在力学和生物功能特性上均可调,使其成为生成可能需要不同微环境的先进类肿瘤模型的有力工具。类肿瘤由在超低吸附U形96孔板中形成的单个球状体生成,随后将其包埋于用我们的无异源补充剂稀释的VitroGel®水凝胶中。在加入水凝胶后的最初三天内,细胞开始从球状体向基质迁移,形成一种具有快速增殖细胞的管状结构。到第七天,类肿瘤表现出富含EMT标志物阳性细胞的外层,这些细胞表达vimentin和N-cadherin,而球状体核心和管状结构则主要由表达癌症干细胞相关标志物Oct4和Sox2的细胞组成。类肿瘤对标准化疗药物敏感,包括替莫唑胺和5-氟尿嘧啶,表明这些在无异源水凝胶中形成的结构是适合药物筛选研究的系统。此外,为增强类肿瘤模型的生理相关性,我们通过将类肿瘤与内皮细胞共培养来模拟肿瘤-血管相互作用。内皮细胞穿透基质并向类肿瘤迁移,增强了它们的长期存活。总之,这些发现表明无异源水凝胶系统支持构建稳健的3D癌症模型,为评估候选治疗药物提供了平台。
查看英文原文 English abstract
Epithelial-to-mesenchymal transition (EMT) is a key biological process that facilitates cancer metastasis to distant organs. Most preclinical studies investigating EMT are conducted using traditional two-dimensional (2D) culture models, which fail to recapitulate the in vivo tumor microenvironment, limiting the translational relevance of their findings to clinical settings. Consequently, three-dimensional (3D) culture systems have emerged as a superior approach for modeling metastatic processes and evaluating therapeutic candidates. However, these models typically rely on animal-derived extracellular matrices like Matrigel, which are poorly defined, exhibit batch-to-batch variability, and lack mechanical and biochemical stability, thereby compromising experimental reproducibility and clinical translation. In this study, we developed tumoroids from two cancer types known to undergo EMT such as glioblastoma multiforme (GBM) and breast cancer using VitroGel® hydrogel, a fully synthetic and biocompatible hydrogel system. The VitroGel® hydrogel is tunable in both mechanical and biofunctional properties, making it a powerful tool for generating advanced tumoroid models that might require distinct microenvironments. The tumoroids were generated from a single spheroid formed in ultra-low attachment, u-shaped, 96-well plates, which were then embedded in VitroGel® hydrogel diluted in our xeno-free supplement. Within the first three days after adding the hydrogel, the cells began migrating from the spheroid into the matrix, developing a tube-like structure with rapidly proliferating cells. By day seven, the tumoroids exhibited an outer layer enriched with EMT marker-positive cells expressing vimentin and N-cadherin, while the spheroid core and tube-like structure were mostly composed of cells expressing the cancer stem cell-associated markers Oct4 and Sox2 . The tumoroids were susceptible to standard chemotherapies, including temozolomide and 5-fluororacil, indicating that these structures developed in the xeno-free hydrogel are a suitable system for drug screening studies.Additionally, to enhance the physiological relevance of the tumoroid model, we aimed to mimic tumor-vasculature interactions by performing co-cultures of tumoroids with endothelial cells. The endothelial cells penetrated the matrix and migrated towards the tumoroids, enhancing their long-term survival. Altogether, these findings demonstrate that the xeno-free hydrogel system supports the development of robust 3D cancer models, providing a platform for the evaluation of therapeutic drug candidates.
利益披露 Disclosure
A. I. Ferrer Díaz, None.. J. Huang, None.

← 返回 AACR 2026 检索